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We had recently reported that the mymA operon (Rv3083 to Rv3089) of Mycobacterium tuberculosis is regu-
lated by AraC/XylS transcriptional regulator VirS (Rv3082c) and is important for the cell envelope of M. tu-
berculosis. In this study, we further show that a virS mutant (MtbvirS) and a mymA mutant (Mtbmym::hyg)
of M. tuberculosis exhibit reduced contents and altered composition of mycolic acids along with the accumu-
lation of saturated C24 and C26 fatty acids compared to the parental strain. These mutants were markedly more
susceptible to major antitubercular drugs at acidic pH and also showed increased sensitivity to detergent
(sodium dodecyl sulfate) and to acidic stress than the parental strain. We show that disruption of virS and
mymA genes impairs the ability of M. tuberculosis to survive in activated macrophages, but not in resting
macrophages, suggesting the importance of the mymA operon in protecting the bacterium against harsher
conditions. Infection of guinea pigs with MtbvirS, Mtbmym::hyg, and the parental strain resulted in an
800-fold-reduced bacillary load of the mutant strains compared with the parental strain in spleens, but not
in the lungs, of animals at 20 weeks postinfection. Phenotypic traits were fully complemented upon reintro-
duction of the virS gene into MtbvirS. These observations show the important role of the mymA operon in the
pathogenesis of M. tuberculosis at later stages of the disease.
Mycobacterium tuberculosis, the etiological agent of ex-
tremely serious human infections, is a highly successful intra-
cellular pathogen because it can adapt itself to various hostile
environments. The cell envelope of mycobacteria is known to
play a major role in their virulence and resistance to hostile
environments. Besides, interaction of the mycobacterial cell
envelope with host cell receptors facilitates uptake of the bac-
terium and modulation of host immune responses (12). Myco-
bacterium tuberculosis has approximately 250 genes involved in
its lipid metabolism, and the lipid contents of the pathogen
contribute to 60% of the cell dry weight (10, 12). A number of
genes involved in the synthesis of essential components of the
cell envelope for maintaining appropriate cell wall architecture
of M. tuberculosis have been identified, and their requirement
for the virulence of M. tuberculosis has been established, sug-
gesting their importance as targets for the development of new
antitubercular drugs (4, 8, 19, 22, 57). Genes responsible for
the biosynthesis of oxygenated mycolic acids and cyclopro-
panated mycolic acids were shown to be important for the in
vivo growth and persistence of M. tuberculosis (19, 22, 57). The
gene cluster involved in the biosynthesis of major complex
lipids phthiocerol and phenolphthiocerol dimycocerosates of
M. tuberculosis have been shown to play an important role in its
virulence (11). Induction of various genes involved in fatty acid
metabolism in caseous granuloma (9) or human macrophages
(20) or after exposure to sodium dodecyl sulfate (SDS) (37, 57)
or acidic stress (21) suggests the importance of fatty acids in
maintaining appropriate cell envelope structure for the sur-
vival of M. tuberculosis upon its exposure to various stressful
conditions encountered in the host. Various reports have sug-
gested that the macrophage environment damages the lipid-
rich cell surface of M. tuberculosis (37, 52). However, the sur-
vival of M. tuberculosis inside the phagosome and upregulation
of a number of genes involved in the modification of the cell
envelope clearly suggest the importance of remodeling the cell
envelope in the intracellular adaptation of the pathogen (57).
The down regulation of the FAS II operon of M. tuberculosis at
acidic pH (21), alterations in the mycolic acid composition of
Mycobacterium smegmatis upon exposure to environmental
stresses like temperature (33), and the requirement of cyclo-
propanated mycolic acids to counter oxidative stress (67) fur-
ther suggest the importance of remodeling the cell envelope
for adaptation of the pathogen under stressful conditions.
We had recently identified mymA operon (named after the
first gene of the operon, Rv3083, which is a homologue of
several monooxygenases present in the M. tuberculosis genome
and thus designated mymA, i.e., mycobacterial monooxygen-
ase) of M. tuberculosis, which is organized divergently to virS,
which acts as a transcriptional regulator of this operon. We had
shown that the promoter of mymA operon is induced in mac-
rophages and upon exposure to acidic pH (58). Also, induction
of the mymA operon by VirS is important for maintaining
appropriate cell envelope structure of M. tuberculosis (58). In
this study, we show that the mymA operon is required for
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maintaining the appropriate mycolic acid composition and per-
meability of the M. tuberculosis envelope on its exposure to
acidic pH. The functional loss of the mymA operon of M. tu-
berculosis resulted in increased drug sensitivity and killing of
the pathogen by activated macrophages and its reduced ability
to persist specifically in the spleen of infected guinea pigs.
Complementation of the virS mutant of M. tuberculosis with a
functional copy of the virS gene resulted in restoration of
wild-type phenotype.
MATERIALS AND METHODS
Bacterial strains and culture conditions.M. tuberculosis Erdman, the parental
strain, mutant strains (MtbvirS and Mtbmym::hyg) and a virS-complemented
strain (MtbvirS_virS) were grown in Middlebrook (MB) 7H9 broth (Difco
Laboratories) supplemented with 0.5% glycerol, 0.2% Tween 80, and 1 ADC
(albumin-dextrose complex; Difco Laboratories) or MB 7H10 medium (Difco
Laboratories) supplemented with 1 OADC (oleic acid-albumin-dextrose com-
plex; Difco Laboratories). Escherichia coli DH5  and HB101 strains were grown
in Luria-Bertani (LB) broth. Bacteria were cultured at 37°C with shaking at 200
rpm, and, whenever appropriate, antibiotics were added at the following con-
centrations: ampicillin, 50 g/ml for E. coli; kanamycin, 25 g/ml for E. coli and
M. tuberculosis; hygromycin B, 150 g/ml for E. coli and 50 g/ml for M. tuber-
culosis.
Recombinant DNA techniques. Mycobacterial genomic DNA was extracted as
described previously (32). Molecular cloning, digestion with restriction endo-
nucleases, and Southern blot hybridization were carried out by standard tech-
niques (54). Restriction endonucleases and other DNA-modifying enzymes (New
England Biolabs Inc.) were used according to manufacturer’s recommendations.
Disruption of the mymA gene of M. tuberculosis. The parent plasmid pSG10
(24), which carries the entire open reading frame of mymA along with upstream
and downstream flanking sequences, was employed for the construction of non-
replicative vector p10mym:hk. Plasmid pSG10 was digested with BglII, which
cleaves the mymA open reading frame at a unique site at its center. This BglII
site was used to clone the hygromycin resistance gene in the mymA open reading
frame. The entire hyg resistance cassette for this purpose was excised as a 1.9-kb
BamHI fragment from the plasmid p10virShyg (58) and ligated with BglII-
digested pSG10 vector to generate p10mym:hyg. This construct was further
modified by cloning the kanamycin resistance gene in the vector backbone. The
kanamycin resistance gene was excised out from pSD5 (15) as an NheI-BstEII
fragment, end repaired, and cloned into DraI-digested p10mym:hyg, resulting in
p10mym:hk.
This plasmid was pretreated with UV radiation (26, 47) and electroporated
into M. tuberculosis. The hygromycin-resistant and kanamycin-sensitive transfor-
mants, resulting from double crossover, were selected on MB 7H10 agar plates.
Loss of mymA (Rv3083) was confirmed by Southern blot and immunoblot anal-
ysis using genomic DNA and cell extracts prepared from the wild-type and mymA
mutant of M. tuberculosis (Mtbmym::hyg).
Construction of the virS complementation strain. For complementation stud-
ies, the complete virS gene along with its upstream sequences containing virS
promoter region was obtained from pSG10 (24) by digesting it with EcoRV-
SmaI. This fragment was cloned into the EcoRV site of mycobacteria-E. coli
shuttle vector pSD5 (15). The resulting plasmid, pSD5virS, was electropo-
rated into the virS mutant strain of M. tuberculosis (MtbvirS) to generate
MtbvirS_virS. Expression of virS in the MtbvirS_virS strain was confirmed by
immunoblot analysis using polyclonal antibodies raised against VirS in rabbit.
Electron microscopy. Transmission electron microscopy was performed as
described previously (58).
Isolation, derivatization, and analysis of fatty acids. The total fatty acids were
extracted from various strains of M. tuberculosis grown to an A600 of 1.5 and
derivatized to UV-absorbing p-bromophenacyl esters as described previously (7).
The separation of fatty acid derivatives was accomplished on a C18 octadecylsilyl
reversed-phase cartridge column (250 by 10 mm, with 5-m-diameter spherical
particles). A solvent gradient of increasing concentrations of p-dioxane in ace-
tonitrile, comprising five linear segments (0 to 10 min, 0% p-dioxane; 10 to 20
min, 0 to 5% p-dioxane; 20 to 40 min, 5 to 50% p-dioxane; 40 to 90 min, 50 to
70% p-dioxane; 90 to 100 min, 70 to 50% p-dioxane and constantly at 50%
p-dioxane) was run with a flow rate of 1 ml/min. Detection was carried out by
monitoring absorbance at 260 nm. The peak produced by the high-molecular-
weight standard (Ribi ImmunoChem Research) was used as a reference peak to
adjust and calculate the relative retention time (RRT). Percent peak height for
each mycolic acid peak was determined as described previously (51). Individual
mycolic acid peaks were labeled according to their RRT as determined from
multiple runs of mycolic acid samples.
Mycolic acid and fatty acid profiles of M. tuberculosis strains grown at acidic
pH. The total fatty acids of various strains of M. tuberculosis growing at either
neutral (7.0) or acidic (5.0) pH were radiolabeled using 1 Ci/ml of 1,2-14C
acetate (50 to 62 mCi/mmol [1.85 to 2.29 GBq/mmol]; Amersham). The radio-
labeled fatty acids and mycolic acids were extracted, methylated, and analyzed by
thin-layer chromatography (TLC) using silica gel plates (Silica gel 60F254;
Merck) as described previously (31). The intensities of radioactive fatty acid
methyl esters (FAMEs) and mycolic acid methyl esters (MAMEs) were detected
and compared using the phosphorimager (Fuji BAS5000). Radioactive FAMEs
and MAMEs were also recovered by chloroform from the TLC plate as described
previously (30) and subjected to a  scintillation counter for determining the
radioactive counts per minute.
Miscellaneous analytical techniques. For matrix-assisted desorption ioniza-
tion–time of flight (MALDI-TOF) analysis, MAMEs were separated from
FAMEs on preparative silica gel-coated TLC plates (20 cm by 20 cm) by devel-
oping in hexane ethyl acetate (95:5) followed by visualization using iodine vapors.
MALDI-TOF spectra (in the positive mode) of purified MAMEs were acquired
on a Bruker ultraflex MALDI-TOF equipped with a pulsed nitrogen laser emit-
ting at 337 nm in the Reflectron mode as described previously (18).
For gas chromatography, equivalent amounts of FAMEs or MAMEs derived
from various strains of M. tuberculosis were injected into a Varian 3800 apparatus
equipped with an HP-5 column (30 m by 0.25 mm by 0.25 m) using nitrogen as
carrier gas (flow rate, 1 ml/min). The temperature separation program involved
an increase from 150°C to 310°C at the rate of 5°C/min, followed by 20 min at
310°C. The injector temperature for analysis was kept at 250°C for FAMEs and
350°C for MAMEs (for thermal cleavage of MAMEs; pyrolytic gas chromatog-
raphy [GC]). The fatty acid peaks were identified by comparing retention times
with authentic fatty acid methyl ester standards (Sigma). The relative percent-
ages of fatty acid peaks were determined by measuring total peak height, and the
percentage of each peak was calculated relative to total peak height.
Drug, detergent, and pH susceptibility/sensitivity assays. The MIC99s of var-
ious antitubercular drugs were determined in triplicate by the serial dilution
plate method as described previously (68). Similarly, the antibiotic sensitivities of
various strains at acidic pH were determined by using modified MB 7H10
medium adjusted to pH 5.0 as described previously (25). The concentration of
antitubercular drugs that resulted in three or fewer colonies was taken as MIC99
and was determined by conducting three independent experiments.
Sensitivity of various M. tuberculosis strains to SDS was determined as de-
scribed by Camacho et al. (8).
To study the effect of acidic pH, cultures were exposed to pH 4.0 either directly
(without preadaptation) or after adaptation at pH 5.0 for 16 to 18 h and percent
survival of bacilli was calculated after exposure to pH 4.0 for various time points.
Preparation of M. tuberculosis cells for virulence studies. Various strains of
M. tuberculosis were processed for virulence studies as described previously (59).
In vitro infection of mouse macrophages by M. tuberculosis. Survival of myco-
bacterial strains in J774A.1 mouse macrophage cells resting or activated with
recombinant gamma interferon (50 U/ml, 16 h) was studied as described earlier
(59).
Studies of virulence in guinea pigs. Virulence of various strains of M. tuber-
culosis was evaluated in guinea pigs as described earlier (44, 59).
Statistical methods. The Student’s unpaired t test was applied for statistical
evaluation of the data assuming normal distribution. A P value of 0.05 was
considered as a statistically significant observation for a parameter.
RESULTS
Disruption of the mymA gene of M. tuberculosis. We have
carried out disruption of mymA (Rv3083), which is the first
open reading frame of the mymA operon, by homologous re-
combination using nonreplicative vector p10mym:hk (Fig. 1).
Electroporation of UV-pretreated p10mym:hk into M. tuber-
culosis resulted in 130 hygromycin-resistant colonies. Allelic
exchange by double crossover should specifically result in the
integration of a disrupted mymA allele (mymA::hyg) and not
the vector backbone (containing a kanamycin resistance cas-
sette). Further screening of hygromycin-resistant colonies
(Hygr) for the kanamycin sensitivity (Kans) phenotype resulted
in isolation of two colonies with the desired Hygr Kans pheno-
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type. The disruption of mymA was confirmed in one Hygr Kans
colony by Southern blot analysis using the genomic DNA from
M. tuberculosis and its mymA mutant strain (Mtbmym::hyg)
(data not shown) and by immunoblot analysis using polyclonal
antibodies raised in rabbit against MymA. The wild-type strain
showed a specific protein band of 55 kDa corresponding to
MymA (Fig. 1B, lane 1), which was absent in the mutant strain
(Fig. 1B, lane 2). mymA represents the first gene of the mymA
operon (Rv3083 to Rv3089). The disruption of the mymA gene
by insertion of the hygromycin resistance (Hygr) cassette re-
sulted in the termination of transcription at the end of the
hygromycin resistance gene (due to the presence of the tran-
criptional terminator). Hence, the downstream genes of the
mymA operon Rv3084 to Rv3089 were not transcribed. This
was confirmed by reverse transcription (RT) analysis. No am-
plified products were obtained by RT-PCR with primers span-
ning the intergenic region of mymA and lipR (Rv3084) or
fadD13 (Rv3089) when the RNA isolated from Mtbmym::hyg
was used, whereas both the primer pairs yielded an RT-PCR
product of the predicted size when RNA from M. tuberculosis
was employed (Fig. 1C). These results confirmed that the dis-
ruption of mymA resulted in functional inactivation of the
mymA operon.
Cell wall ultrastructure of the mymA mutant of M. tubercu-
losis. We have previously shown that expression of the mymA
operon requires the presence of VirS and that the virS mutant
of M. tuberculosis (MtbvirS) exhibits altered cell wall ultra-
structure (58). Thus, to confirm that the observed phenotype of
MtbvirS was due to abolished expression of mymA operon,
the cell wall of an mymA mutant (Mtbmym::hyg) was analyzed
by transmission electron microscopy (TEM) as described pre-
viously (58). We observed significant alterations in the cell wall
of the Mtbmym::hyg strain, which were identical to the alter-
ations observed in the case of the virS mutant of M. tuberculosis
FIG. 1. (A) Disruption of the mymA (Rv3083) gene of M. tuberculosis. Shown is the schematic organization of the mymA operon of M. tu-
berculosis with a disrupted mymA (Rv3083) gene. Thick arrow, hygromycin resistance gene, which was used both as a disruption element and as
a selection marker. MF1-LR1 and FdF1-FdR1 represent primer pairs used to confirm the effect of disruption on the transcription of downstream
genes. Predicted sizes of the amplicons using the primer pairs MF1-LR1 and FdF1-FdR1 are shown. (B) Expression of mymA in M. tuberculosis
and Mtbmym::hyg. The cell extract (50 g protein) from M. tuberculosis (lane 1) and Mtbmym::hyg (lane 2) was resolved on a 10% polyacrylamide
gel containing 0.1% SDS and transferred to a Hybond C Extra membrane. The blot was probed using polyclonal antibodies raised in rabbit against
MymA. (C) Influence of disruption of mymA on the expression of downstream genes of the mymA operon. RT-PCR products corresponding to
mymA-lipR intergenic region and the fadD13 gene were amplified using primer sets MF1-LR1 (lanes 1 to 4) and FdF1-FdR1 (lanes 5 to 8),
respectively. In the negative control (), the PCRs were performed directly on the total RNA isolated from Mtbmym::hyg (lanes 1 and 5) and M.
tuberculosis (lanes 3 and 7) to confirm the absence of DNA contamination. RT-PCR was performed on the RNA obtained from Mtbmym::hyg
(MF1-LR1, lane 2; FdF1-FdR1, lane 6) and M. tuberculosis (MF1-LR1, lane 4; FdF1-FdR1, lane 8). The size of the PCR product is consistent with
the predicted size shown in the figure. M, 100-bp marker (U.S. Biochemicals).
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(MtbvirS) (Fig. 2) (58). This confirmed that the disruption of
mymA or virS results in similar phenotypes. A dense staining of
the electron-transparent zone (ETZ) observed in the case of
MtbvirS and Mtbmym::hyg cells due to compromised perme-
ability of the cell wall is suggestive of alterations in the mycolic
acids present in the lipid bilayer (65).
Influence of virS and mymA disruption on the mycolic acid
profile ofM. tuberculosis. To investigate if the observed changes
in the staining pattern of the ETZ were associated with alter-
ations in the mycolic acids, we compared the profiles of mycolic
acids extracted from the MtbvirS, Mtbmym::hyg, virS-comple-
mented (MtbvirS_virS), and parental strains of M. tuberculo-
FIG. 2. Effect of mymA disruption on the cell wall ultrastructure of M. tuberculosis. The cell wall of M. tuberculosis and Mtbmym::hyg was
examined by transmission electron microscopy. Cells were cultured in MB 7H9 medium to an A600 of 1.5, harvested, washed with phosphate buffer,
and fixed in paraformaldehyde solution for 4 to 8 h. Cells were prepared for electron microscopy as described earlier (58). Shown is electron
microscopic analysis (44,000) of (A) M. tuberculosis and (B) Mtbmym::hyg. The photomicrographs shown are typical of the population as a whole,
as judged by viewing many independent fields.
FIG. 3. Representative HPLC chromatograms of mycolic acids from various strains of M. tuberculosis. M. tuberculosis MtbvirS, Mtbmym::hyg,
and MtbvirS_virS strains were inoculated separately in MB 7H9 medium and grown to an A600 of 1.5. Total fatty acids were extracted, derivatized
to UV-absorbing p-bromophenacyl esters, and separated by HPLC as described in Materials and Methods. Shown are mycolic acid profiles of
(A) M. tuberculosis, (B) MtbvirS, (C) Mtbmym::hyg, and (D) MtbvirS_virS from HPLC analysis. Peaks were labeled according to their RRTs.
IS, internal high-molecular-weight standard. Arrows indicate the significant differences in the mycolic peaks between various strains.
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sis by high-pressure liquid chromatography (HPLC). Strains
were grown in 7H9 medium, and extreme care was taken to
maintain the medium composition and culture conditions ex-
actly the same for culturing various strains. As shown in Fig. 3,
there were clear differences in the profiles of mycolic acids
isolated from the MtbvirS and Mtbmym::hyg strains when
compared with the parental strain of M. tuberculosis. While the
parental strain showed peak G as the most prominent peak, in
the case of the MtbvirS and Mtbmym::hyg strains, peaks H
and F were most prominent, as determined by calculating
relative percent peak height (Fig. 3). Reintroduction of wild-
type virS gene into the MtbvirS strain fully restored its my-
colic acid profile to the normal profile as exhibited by the
parental strain (Fig. 3D). Furthermore, TLC analysis followed
by radioactive quantification revealed alterations in the FAMEs
and MAMEs of the mutants compared to parental strain of
M. tuberculosis. Approximately 30% 	 2.9% reduction and
10% 	 2% accumulation of radioactivity associated with the
MAME and FAME fractions of MtbvirS and Mtbmym::hyg,
respectively, compared to the parental strain were found (Fig.
4A). These differences in the MAMEs and FAMEs isolated
from MtbvirS and Mtbmym::hyg strains were fully comple-
mented in the MtbvirS_virS strain of M. tuberculosis.
MALDI-TOF analysis of MAMEs from various strains of
M. tuberculosis growing at pH 7.0 showed no qualitative dif-
ference in the mycolic acids; however, there were quantitative
differences in mycolic acid species produced by parental and
mutant strains. While, in the case of mutant strains MtbvirS
and Mtbmym::hyg, the most prominent mycolic acid peaks were
represented by masses 1202 and 1316, in the case of parental
strain the most prominent mycolic acid peaks were represented
by masses 1174, 1230, 1262, 1290, and 1318 (Fig. 5). The virS-
complemented strain (MtbvirS_virS) showed a distribution of
mass intensities indistinguishable from the pattern observed
in the parental strain (Fig. 5D). Thus, the data from four
independent analytical techniques (TEM, HPLC, TLC, and
MALDI-TOF) confirm the role of the mymA operon in main-
taining appropriate cell wall structure and mycolic acid com-
position of M. tuberculosis.
Influence of acidic stress on the mycolic acid profile of
M. tuberculosis. In our earlier study, based on the up regulation
of the mymA operon at acidic pH, we had suggested its role in
the modification of the cell envelope of M. tuberculosis in re-
sponse to acidic stress. Since disruption of the mymA operon
resulted in alterations in the mycolic acids of M. tuberculosis,
we further analyzed the role of this operon in the modification
of mycolic acids upon exposure to acidic stress. Alteration of
growth conditions from pH 7.0 to pH 5.0 resulted in a general
decline in MAMEs and consequent increase in FAMEs in both
the mutants as well as the parental strains (Fig. 4B). However,
the amount of MAMEs in the mutant strains (MtbvirS and
Mtbmym::hyg) was 50% 	 6.4% lower compared to the paren-
tal strain. In contrast, the amount of FAMEs in these mu-
tant strains was 20% 	 3.1% higher compared to the parental
strain (Fig. 4B).
Further, we carried out MALDI-TOF analysis of the
MAMEs extracted from various strains of M. tuberculosis ex-
posed to acidic pH. As shown in Fig. 5, exposure to acidic pH
resulted in general suppression of most of the psuedomolecu-
lar ion [MNa] peaks observed at neutral pH. In addition to
FIG. 4. Thin-layer chromatography of FAMEs and MAMEs from various strains of M. tuberculosis. M. tuberculosis, MtbvirS, Mtbmym::hyg,
and MtbvirS_virS strains were grown to an A600 of 1.5 in MB 7H9 medium, adjusted either to pH 7.0 or to pH 5.0, and labeled with 1 Ci/ml
[1,2-14C]acetate for 12 h. Labeled lipids were extracted, derivatized to methyl esters, and resolved by normal phase TLC using petroleum
ether/diethyl ether (17:3). Equal counts (200,000 cpm) were loaded in each lane, and a phosphorimager was used to quantify the proportion of
FAMEs and MAMEs derived from various strains of M. tuberculosis. Shown are TLC profiles of total fatty acid esters (FAMEs and MAMEs)
extracted from M. tuberculosis, MtbvirS, Mtbmym::hyg, and MtbvirS_virS strains growing at (A) neutral pH (7.0) or (B) acidic pH (5.0). These
experiments were repeated four times, and similar results were obtained.
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the common peaks observed in all strains of M. tuberculosis, in
the parental and MtbvirS_virS strains, few psuedomolecular
masses unique to acidic pH were observed; these included m/z
1271, 1328, 1356, and 1384 (Fig. 5E and H). The latter three
mass intensities (1328 to 1384) differed from each other by 28
amu and represent homologous series of mycolic acids differ-
ing by a C2 carbon unit (approximately C88 to C92). More
importantly, these three mass intensities were not observed in
the MALDI-TOF chromatogram of MAMEs extracted from
MtbvirS and Mtbmym::hyg strains growing at acidic pH (Fig.
5F and G). These results clearly demonstrate the involvement
of the mymA operon in the modification of mycolic acids of
M. tuberculosis upon exposure to acidic stress.
Inactivation of mymA or virS leads to accumulation of C24:0
and C26:0 fatty acids. Our TLC experiments showed a consis-
tent increase of 10% to 20% in the radioactivity associated
with FAMEs extracted from MtbvirS and Mtbmym::hyg com-
pared to the parental strain. To identify the fatty acids respon-
sible for this increase in the mutant strains, the FAMEs from
various strains were extracted and subjected to GC. Our GC
data showed alterations in the amount of C26:0, C24:0, C16:0,
and C18:3 (tuberculostearic acid [TBS]) in the mutant strains
FIG. 5. MALDI-TOF mass spectra of MAMEs from various strains of M. tuberculosis. M. tuberculosis, MtbvirS, Mtbmym::hyg, and MtbvirS_virS
strains were grown in MB 7H9 medium at pH 7.0 or exposed to pH 5.0 for 12 h. MAMEs were extracted and subjected to MALDI-TOF analysis
as described in Materials and Methods. MALDI-TOF mass spectra of MAMEs from M. tuberculosis (A and E), MtbvirS (B and F), Mtbmym::hyg
(C and G), and MtbvirS_virS (D and H) are shown. The psuedomolecular masses of mycolates are indicated on each mass spectrum. Arrows and
brackets indicate the major differences observed in MALDI-TOF analysis of MAMEs from various strains.
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when compared with the parental and MtbvirS_virS strains.
While the relative percentage of other detectable fatty acids
C18:1 and C18:0 remained unaltered, we observed a twofold de-
crease in the levels of C16:0 and TBS and threefold and twofold
increases in the levels of C26:0 and C24:0 fatty acids, respec-
tively, in MtbvirS and Mtbmym::hyg compared to the parental
and MtbvirS_virS strains (Fig. 6). Similar alterations in the
fatty acid profiles of MtbvirS and Mtbmym::hyg were ob-
served by HPLC analysis (data not shown). The identities of
the accumulated fatty acids were confirmed by using authentic
fatty acid standards for GC and by electrospray-mass spec-
trometry of accumulated fatty acids collected from HPLC
(data not shown). These data strongly suggest that the accu-
mulation of C26:0 and C24:0 fatty acids in the mutants might
lead to the reduced synthesis of mycolic acids in these strains.
Influence of virS and mymA disruption on the mycolic acid
cleavage products of M. tuberculosis. Association between dis-
ruption of the mymA operon, reduced synthesis of mycolic
acids, and accumulation of C24:0 and C26:0 fatty acids suggested
utilization of these fatty acids in the synthesis of mycolic acids
FIG. 6. Gas chromatograms of FAMEs from various strains of M. tuberculosis. FAMEs were extracted from various strains of M. tuberculosis
and analyzed by gas chromatography as described in the Materials and Methods. The identity of fatty acid peaks was confirmed by using authentic
fatty acid standards. Relative percentages of fatty acids were calculated and are indicated on each chromatogram. FID and TBS represent flame
ionization detector and tuberculostearic acid, respectively. The values shown are averages of three independent experiments	 standard deviations.
(A) M. tuberculosis; (B) MtbvirS; (C) Mtbmym::hyg, (D) MtbvirS_virS. Accumulation of C26:0 and C24:0 in the mutant strains is indicated by
arrows. These experiments were repeated three times with similar results.
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by the mymA operon. Thus, we examined the role of this op-
eron, if any, in condensing saturated C24 and C26 fatty acids
with meromycolic acid. It has been shown in several studies
that increasing the injector temperature of GC to 350°C (py-
rolytic GC) results in complete thermal cleavage of C24:0 and
C26:0 fatty acids condensed to form mycolic acids of M. tuber-
culosis (23, 29, 30).
We observed that the thermal cleavage of mycolic acids
released an approximately twofold-higher proportion of C26:0
fatty acids compared to C24:0 fatty acids in the case of the
parental strain of M. tuberculosis (Fig. 7A). This observation is
consistent with the various reports demonstrating a relatively
higher release of C26:0 fatty acids in comparison to C24:0 fatty
acids from mycolic acids of M. tuberculosis as a result of ther-
mal cleavage (29, 36). However, pyrolysis of mycolic acids from
the mutant strains revealed a strikingly reverse pattern of C26:0
and C24:0 fatty acids, where there was an approximately two-
fold-higher proportion of C24:0 fatty acids released in compar-
ison to C26:0 fatty acids (Fig. 7B and C). These alterations in
the pyrolysis of mycolic acids were fully complemented in the
case of MtbvirS_virS (Fig. 7D).
Simultaneously, we also extracted and analyzed all the polar
and nonpolar lipids as described previously (3, 31), however,
we observed no change in the profiles of these lipids from the
mutants and parental strain of M. tuberculosis (data not
shown). The accumulation of C26:0 and C24:0 fatty acids along
FIG. 7. Pyrolytic gas chromatography of MAMEs from various strains of M. tuberculosis. The MAMEs from various strains of M. tuberculosis
were subjected to thermal cleavage by increasing the injector temperature to 350°C, and the identity of mycolic acid cleavage product (MACP)
was confirmed by using an authentic fatty acid methyl ester standard. (A) M. tuberculosis; (B) MtbvirS; (C) Mtbmym::hyg; (D) MtbvirS_virS. FID
and TBS represent flame ionization detector and tuberculostearic acid, respectively.
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with the altered mycolic acid profile in the mutants indicates
the role of mymA operon in the synthesis of mycolic acids by
utilizing saturated C26 and C24 fatty acids as potential precur-
sors.
Disruption of virS and mymA results in enhanced suscepti-
bility of M. tuberculosis to antibiotics, detergents, and acidic
pH. Mycolic acids are essential components of the mycobacte-
rial cell wall; thus we reasoned that alterations in the mycolic
acids of mutants might affect their ability to resist drugs, de-
tergent, or stress like acidic pH. We show that MtbvirS and
Mtbmym::hyg exhibit a fourfold-higher sensitivity towards ri-
fampin and ciprofloxacin and twofold-higher sensitivity to-
wards isoniazid (INH) in comparison to the parental strain
(Table 1). Furthermore, these mutants showed a significantly
enhanced susceptibility towards the antibiotics at acidic pH. At
pH 5.0, MtbvirS and Mtbmym::hyg strains were fourfold more
sensitive to INH and eightfold more sensitive to rifampin and
ciprofloxacin compared to the parental strain. However, the
most striking difference was observed in case of susceptibility
of the mutant strains towards pyrazinamide (PZA), an antitu-
bercular drug that is active specifically at acidic pH (38, 69). A
50-fold-lower concentration of PZA was sufficient to inhibit
the growth of mutant strains in comparison to the concentra-
tion required to inhibit the growth of the parental strain
(Table 1). These mutants also exhibited greater sensitivity to
SDS compared to the parental strain (Fig. 8A). MtbvirS and
Mtbmym::hyg were also drastically sensitive to acidic pH (pH
4.0) when compared with the parental strain (Fig. 8B). More
importantly, prior adaptation of the parental strain to pH
5.0 significantly increased its survival at pH 4.0 (by fourfold
[P 
 0.02]), although no such influence of adaptation was
observed in the case of mutant strains (Fig. 8B). The pheno-
types exhibited by the mutants were fully complemented in the
MtbvirS_virS strain of M. tuberculosis.
Role of the mymA operon in the in vivo survival of M. tuber-
culosis in macrophages and guinea pigs. Resting and acti-
vated murine macrophage cells were infected with MtbvirS,
Mtbmym::hyg, MtbvirS_virS, and the parental strain of M.
tuberculosis, and the survival of intracellular bacteria was de-
termined on days 0, 2, 4, and 6 postinfection. All strains grew
FIG. 8. (A) Susceptibility of various strains of M. tuberculosis to SDS. M. tuberculosis, MtbvirS, and Mtbmym::hyg strains were inoculated
separately in MB 7H9 medium and grown to an A600 of 1.5. Cultures were exposed to 0.01%, 0.04%, and 0.1% SDS for the indicated periods of
time, and the number of viable bacilli was evaluated by plating on MB 7H10 medium. CFU obtained immediately after the exposure to SDS (1
108 to 2  108 cells per ml) were taken as 100 percent viability. Percent survival for each strain was calculated, and the figure represents percent
survival upon exposure to 0.1% SDS. The experiment was carried out thrice in triplicate, and the data are depicted as the mean 	 standard errors
(SE). (B) Influence of disruption of virS and mymA on the acid tolerance response of M. tuberculosis. M. tuberculosis, MtbvirS, Mtbmym::hyg, and
MtbvirS_virS were grown in MB 7H9 medium (pH 7.0) to an A600 of 1.5. Cultures were exposed either directly to pH 4.0 or after preadaptation
at pH 5.0 for 16 to 18 h. Viable counts were taken at 12 h and 24 h after exposure to pH 4.0. Percent survival was calculated as described in
Materials and Methods. Viable counts obtained immediately after exposure to pH 4 (4  107 cells per ml) were taken as 100 percent viability,
and percent survival was calculated at various time points. The figure represents percent survival at 24 h postexposure. The experiment was carried
out twice in triplicate, and the data are depicted as the means 	 SE.
TABLE 1. Influence of virS and mymA disruption on the susceptibility of M. tuberculosis to antibioticsa
Strain
MIC99 (g/ml) at indicated pH of:
Rifampin Ciprofloxacin Isoniazid Ethambutol Pyrazinamide
7.0 5.0 7.0 5.0 7.0 5.0 7.0 5.0 5.0
M. tuberculosis Erdman 0.50 0.50 1.0 1.0 0.10 0.10 0.10 0.10 50
MtbvirS 0.125 0.0625 0.25 0.125 0.05 0.025 0.10 0.10 1
Mtbmym::hyg 0.125 0.0625 0.25 0.125 0.05 0.025 0.10 0.10 1
MtbvirS_virS 0.50 0.50 1.0 1.0 0.10 0.10 0.10 0.10 50
a The MIC99 values were determined as described in Materials and Methods. Three independent experiments were carried out, and the same MIC99 values were
obtained.
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at comparable rates inside the resting macrophages (Fig. 9A);
however, there were four- and eightfold reductions in the num-
ber of intracellular mutant bacilli compared to parental bacilli
in activated macrophages at 4 and 6 days, postinfection (Fig.
9B). We further extended our study to investigate the role of
the mymA operon in the survival of M. tuberculosis in guinea
pigs.
In a preliminary study, we observed that 6 weeks after in-
fection with either MtbvirS or the parental strain, the animals
showed similar patterns of infection, with no differences in the
pathophysiology as well as bacillary load in spleen and lung
(data not shown). Thus, we further extended our study to de-
termine the role of the mymA operon in the later stages of the
disease. For this, guinea pigs were infected subcutaneously
with MtbvirS, Mtbmym::hyg, MtbvirS_virS, and the parental
strain of M. tuberculosis and the animals were euthanized at 10
and 20 weeks postinfection. It was observed that there was no
significant difference in the scores and the lung and splenic
CFU obtained for various groups of animals at 10 weeks post
infection (data not shown). However, at 20 weeks postinfec-
tion, the total scores of the animals infected with MtbvirS
and Mtbmym::hyg strains were significantly lower (17.50 and
24.0, respectively) in comparison to the total scores of ani-
mals infected with the parental strain (57.25, P 
 0.02) and
MtbvirS_virS (56.50, P 
 0.02). These results were further
strengthened by a significant reduction of bacillary load in the
spleen of animals infected with the MtbvirS (log10, 4.74) and
Mtbmym::hyg (log10, 4.71) compared to the bacillary load in
the spleen of animals infected with the parental strain (log10,
7.72, P 
 0.003) and the MtbvirS_virS strain (log10, 7.63, P 

0.002) (Fig. 9C). Thus, an approximately 800-fold (2.8 log)-
reduced bacillary load was observed in spleens of animals in-
fected with the mutant strains in comparison to the animals
infected with the parental strain. However, the bacillary load in
lungs of animals infected with MtbvirS (log10, 7.19) and
Mtbmym::hyg (log10, 7.25) was comparable to the bacillary load
FIG. 9. Effect of virS and mymA disruption on the in vivo survival of M. tuberculosis in macrophages and guinea pigs. The mouse macrophage
cells (J774A.1) were infected with M. tuberculosis, MtbvirS, Mtbmym::hyg, and MtbvirS_virS strains separately at an multiplicity of infection of
1:10 (macrophage:bacilli). At different time points postinfection (days 0, 2, 4, and 6), macrophages were lysed and the number of intracellular bacilli
was assessed by plating on MB 7H10 (A, resting macrophages; B, activated macrophages). The experiment was carried out twice in triplicate, and
data depict the means of all six values 	 standard errors (SE). Guinea pigs were infected with 5  107 CFU of different strains of M. tuberculosis,
subcutaneously. Infected guinea pigs (five animals per group at each time point) were euthanized at 10 weeks and 20 weeks postinfection. Spleens
and lungs were homogenized in 5 ml of distilled water and 10-fold serial dilutions of the homogenates were plated in duplicate on MB 7H10 medium.
Bacillary load in the spleens and lung of guinea pigs euthanized at 20 weeks (C and D, respectively) postinfection is depicted as mean 	 SE.
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in the lungs of animals infected with the parental strain (log10,
7.25) and MtbvirS_virS strain (log10, 7.21) (Fig. 9D). These
observations were further substantiated by significant differ-
ences in the percent spleen weight per total body weight in case
of animals infected with MtbvirS (0.16%) and Mtbmym::hyg
(0.18%) in comparison to the animals infected with the paren-
tal strain (0.31%, P 
 0.05) and MtbvirS_virS strain (0.36%,
P 
 0.05); however, we observed no difference in the percent
lung weight per total body weight of animals infected with ei-
ther the mutants or parental strain. These observations strong-
ly suggest the role of the mymA operon in the survival of M.
tuberculosis against potentially harsher conditions faced by the
pathogen in activated macrophages and also at later stages of
progression of disease in guinea pigs.
DISCUSSION
In an earlier study, we had reported that the mymA operon
of M. tuberculosis is induced at acidic pH in macrophages and
is transcriptionally regulated by VirS (58). We had also shown
that MtbvirS has an altered cell wall structure and proposed
that these alterations were due to abolished expression of the
mymA operon. More direct proof of this observation emerged
upon disruption of mymA (Rv3083), the first gene in the mymA
operon, which resulted in the functional inactivation of the
mymA operon and similar alterations in the cell wall ultrastruc-
ture phenotype as were observed earlier for MtbvirS (58).
The Mtbmym::hyg strain exhibited a much denser and darker
staining of cell surface, indicating an alteration in the ETZ,
which is thought to be composed primarily of mycolic acids
arranged perpendicular to the plane of the cell surface (5, 33,
34, 35, 48). Such dense staining of the cell wall has also been
observed after treatment of Mycobacterium avium with isonia-
zid resulting from the inhibition of mycolic acid synthesis by
the drug (42). The alterations in the cell surface of MtbvirS
and Mtbmym::hyg strains were further substantiated by the
HPLC profiles of mycolic acids from the mutants and the
parental strains. Furthermore, both mutants produced less my-
colic acids in comparison to the parental strain as analyzed by
TLC. These findings suggest that the observed alterations in
the cell wall ultrastructure result from the altered mycolic acid
composition although the effect of latter on the arrangement of
other cell surface lipids and proteins and their consequent
contribution on the observed phenotype cannot be completely
ruled out. On exposure to acidic pH, the reduction in mycolic
acid synthesis was markedly more prominent in the MtbvirS
and Mtbmym::hyg strains in comparison to the parental strain.
The accumulation of fatty acids (C24:0/C26:0) at acidic pH was
also observed to be higher in the mutants compared to the
parental strain. Although, a general reduction in the synthesis
of mycolic acids at acidic pH can be expected to stem from the
repression of the Fas II operon (21), a much sharper decline in
mycolic acid synthesis in case of both the mutant strains im-
plicates the mymA operon in the synthesis of mycolic acids on
exposure of the pathogen to acidic pH. The emergence of new
mass peaks corresponding to the C88 to C92 chain length of
mycolic acids (1328, 1356, and 1384) in the parental strain, but
not in the mutants, clearly suggested the role of the mymA
operon in the synthesis of these mycolic acids at acidic pH.
Such modifications in the chain length of mycolic acids in
mycobacteria on exposure to environmental stresses have been
reported in several studies (2, 31, 33, 63, 64), emphasizing the
requirement of the appropriate repertoire of mycolic acids to
respond to environmental stresses. Further, the enhanced ac-
cumulation of C24:0/C26:0 fatty acids in the mutant strains sub-
stantiates their role in the synthesis of mycolic acids by the
mymA operon. Conventionally mycolic acids are believed to be
synthesized by elongating long chain fatty acids (C16 to C26) to
meromycolic acids by the Fas II operon of M. tuberculosis, and
the final Claisen type condensation of the C24:0/C26:0 fatty acid
with meromycolates results in the production of full-length
mycolic acids (6, 16, 33, 35, 41, 43). However, Asselineau et al.
(1) have thoroughly reexamined the pathways of mycolic acid
synthesis and suggested an alternate approach of mycolic acid
synthesis by “head-to-tail” condensation of long chain fatty
acids. The synthesis of mycolic acids by this approach involves
the condensation of three common fatty acids. First, two of
these are subjected to omega oxidation followed by condensa-
tion to produce meromycolic acids, which in turn condense
with C24:0/C26:0 fatty acids to produce mycolic acids. This ap-
proach of mycolic acid synthesis requires enzymes that can
carry out omega oxidation of fatty acids and their subsequent
condensation (1). Interestingly, analysis of gene products of
the mymA operon revealed that Rv3083 (mymA) is a homo-
logue of flavin-containing monooxygenases (58), which can
carry out omega hydroxylation of fatty acids (39, 45), the first
step in omega oxidation of fatty acids, while Rv3085 and
Rv3086 show homologies with dehydrogenases and could pos-
sibly carry out subsequent steps to convert terminal methyl
groups of fatty acids to carboxylic groups for condensation as
described previously (1). Release of acyl carrier protein ester-
ified to the fatty acids by thioesetrase LipR (Rv3084) leads
to generation of diacids for the condensation. Rv3087 and
Rv3088 contain an HHXXXDG motif required for the thio-
esterification or Claisen type condensation of fatty acids (28,
46); the last gene, Rv3089, is an acyl-CoA synthase and can
activate the fatty acids. Thus, Rv3087 and Rv3088 can carry out
“head-to-tail” condensation of fatty acids which were previ-
ously omega oxidized by gene products of Rv3083 to Rv3086
and further activation of the condensed fatty acids by Rv3089
can yield long chain fatty acids (keto acids). These keto acids
can then be subjected to functional group modification like
methylation, decarboxylation, or cyclopropanation to generate
meromycolic acids as suggested previously (1). The condensa-
tion process described above can produce long chain fatty acids
that are indistinguishable from mycolic acids (1). Thus, the
genes present in the mymA operon can assemble meromycolic
acids beginning from the omega oxidation of fatty acids fol-
lowed by their condensation with fatty acids (C24:0/C26:0) to
produce mycolic acids as shown in Fig. 10.
Both the mutants showed increased sensitivity to major an-
titubercular drugs along with enhanced susceptibility to SDS
and acidic pH. The enhanced susceptibility of M. tuberculosis
to antibiotics, detergents, and environmental stresses has been
shown to be associated with alterations in the mycolic acid
contents and composition (27, 67, 68). A mutant of Mycobac-
terium smegmatis devoid of mycolic acids has been shown to be
hypersusceptible to antibiotics and was unable to grow at 37°C
(33), while inactivation of the arylamine N-acetyltransferase
gene of Mycobacterium bovis BCG perturbed biosynthesis of
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mycolic acids, with the consequent increase in the sensitivity to
antibiotics (4). Interestingly, these mutants were susceptible to
INH, which is known to target mycolic acid biosynthesis (53,
60, 61, 62, 66). The precise target of INH in M. tuberculosis is
still debatable, and various pieces of evidence suggest that
there might be several targets of INH (60). However, INH-
treated M. tuberculosis accumulates C26:0 fatty acid (41), sug-
gesting that INH targets enzymes which utilize C26:0 for gen-
eration of mycolic acids. These observations, together with the
fact that the mymA operon might utilize C26:0 fatty acids as
precursors for mycolic acid biosynthesis, suggest the possibility
that the proteins present in this operon are potential targets of
INH. This possibility is further strengthened by the presence of
a NADH binding site in MymA (58), which has been shown as
the target of the active form of INH (iso-NAD) in the case of
InhA (17).
The induction of the mymA operon at acidic pH and a
significantly reduced ability of MtbvirS and Mtbmym::hyg to
survive in the activated macrophages compared to the parental
strain supports the hypothesis that the mymA operon may play
an important role in the survival of M. tuberculosis upon expo-
sure to severely acidic conditions in activated macrophages
(56) or caseating granuloma in the later stages of infection (13,
14). This was substantiated by a drastic reduction (2.8 log)
observed in the ability of the mutant strains to specifically
survive in spleen compared to the parental strain at 20 weeks
postinfection. The involvement of the mymA operon in persis-
tence during the chronic stage of disease and also the tropism
shown by the pathogen are not surprising. Several genes in-
volved in fatty acid metabolism such as icl, encoding isocitrate
lyase (catabolizes fatty acids via the glyoxylate cycle) and pcaA,
encoding cyclopropane synthase (required for cyclopropana-
tion of mycolic acids), and mutations affecting the lipid-rich
cell envelope are all known to reduce the survival of M. tuber-
culosis in mice, only at the later stages of disease progression
(22, 40, 55). Besides, several gene disruption studies have led
to the exhibition of tropism by the mutant bacilli; for exam-
ple, FadD28, FadD33, Pps, MmpL7, and HBHA mutants all
showed tissue-specific growth rates (11, 49, 50). This tropism
could be due to different physiological conditions or immune
responses which the pathogen encounters in different organs.
The genes present in the mymA operon apparently may be
involved in maintaining the cell wall integrity required for the
persistence of M. tuberculosis in spleen.
The involvement of the mymA operon in the persistence of
M. tuberculosis together with its role in maintaining appropri-
ate mycolic acid composition to resist antitubercular drugs at
acidic pH indicate that precise targeting of the mymA operon
gene products may increase the effectiveness of combination
chemotherapy and impede the mechanisms involved in the
persistence of M. tuberculosis.
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